What You Should Know: - COTA, Inc., an oncology real-world data and analytics company, today announced a new partnership with Genomic Testing Cooperative (GTC), a molecular testing company. - GTC has a very innovative approach to genetic testing, providing molecular information which is critical to determining accurate diagnoses and determining the most appropriate treatment. GTC's tissue and liquid-biopsy testing leverages DNA and RNA sequencing, which is very rare in the
Read More
Genomic Testing
Primary Care Shifts to Pharmacy and Retail Clinic Settings, Survey Reveals
What You Should Know: - Primary care is continuing to decentralize with more decisions made outside of primary care offices, according to a recent report by Wolters Kluwer. - The Pharmacy Next: Health Consumer Medication Trends survey explores consumer sentiment amid this shift, and offers insight into what safeguards are needed to address their top concerns around medication-related care. Research-Driven Prospects Regarding Changes in American Primary Healthcare The Pharmacy Next:
Read More
Pharmacogenomics: The Key to Unlocking the Future of Personalized Healthcare
Pharmacogenomics—the study of genetic influences on an individual's response to therapeutic medications—is an area of personalized medicine that is gaining momentum. Although pharmacogenomics has been around for a while, providers, health plans, pharmacists and legislators are developing a greater appreciation for its potential benefits and applications. How Can Pharmacogenomics Improve Outcomes? By considering a person’s DNA in treatment options, providers can determine how an
Read More
Syapse and Pierian Partner to Power Precision Oncology
What You Should Know: - Syapse, a real-world evidence company is teaming up with Pierian®, a provider of advanced clinical genomics technology on a new joint collaboration that will benefit patients of the AdventHealth Cancer Institute in Central Florida. - The collaboration combines Syapse’s real-world evidence solutions designed to improve outcomes for patients with cancer, Pierian’s leading-edge clinical genomics workflow, and precision medicine services that provide the most relevant
Read More
NCODA & XIFIN Launch Initiative to Expand Oncology Patient Care Options
What You Should Know: - XIFIN has partnered with NCODA, Inc., a globally recognized association that develops unique resources to help medically integrated oncology teams deliver top-tier care. This new strategic partnership “NCODA Informatics Initiative Powered by VisualStrata” provides the use of VisualStrata as part of the NCODA membership. - As oncology groups work to find and secure clinical trials – thereby expanding patient care options within their practice – purpose-built
Read More
Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration
Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the acquisition of DIABNEXT, a Paris-based company whose digital health platform helps people with diabetes better manage their conditions and connects to their healthcare providers, so they can
Read More
Meaningful Use of Genomics Requires Informatics Beyond EMRs
Electronic medical records (EMRs) are widely expected to serve as a cornerstone technology that drives the delivery of modern patient care. But can the EMR alone support all the informatics capabilities required by an ever-evolving healthcare industry? The rapid growth of precision medicine, particularly the use of genetic and genomic information during clinical decision making, is a compelling example that functionality beyond the EMR is required. Not only does genomic data represent a
Read More
Eliminating the Long, Cumbersome and Costly Diagnosis of Genetic Diseases
The answer to questions about human disease can be found in our genes. The difficulty in the past has been the testing process, a sort of trial and error approach of drilling down into the multitude of variants that can be found within the genes, variants that when analyzed in tandem with detailed clinical histories can actually tell the story and lead to a faster diagnosis. Human beings carry around 20,000 genes and, of those, approximately 5,000 are somewhat understood, and those genes can
Read More
Rady Children’s Exploring Drone Delivery of Genomic Samples to Lab
- Deloitte and Rady’s Children’s Institute for Genomic Medicine (RCIGM) announced an innovative new project to explore the use of unmanned aircraft systems (UAS) known as drones to deliver genomic samples to the laboratory.- This approach seeks to cut down on ground traffic delays by flying genomic testing specimens to the lab, cutting the time needed to get results back to acutely ill babies and children.- The project is in the planning stages; Deloitte and RCIGM are working in coordination
Read More
CVS Health Launches Transform Oncology Care Program, Partners with Tempus
- CVS Health launches Transform Oncology Care, which includes a comprehensive, first-of-its-kind precision medicine approach to oncology management for payors in collaboration with Tempus.- Transform Oncology Care includes an innovative precision medicine strategy that increases access to broad-panel gene sequencing tests for patients diagnosed with certain advanced-stage cancers. - The program also uses CVS’ local footprint and unique assets to improve patient outcomes and lower costs every
Read More
